Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-201,694
Closed -$3.9M 142
2023
Q3
$3.9M Sell
201,694
-1,916
-0.9% -$35.3K 1.33% 17
2023
Q2
$3.46M Sell
203,610
-12,675
-6% -$241K 1.1% 29
2023
Q1
$4.15M Sell
216,285
-41,560
-16% -$715K 1.34% 20
2022
Q4
$3.78M Sell
257,845
-43,300
-14% -$632K 1.07% 36
2022
Q3
$4.25M Sell
301,145
-47,539
-14% -$763K 1.21% 28
2022
Q2
$5.89M Buy
348,684
+32,000
+10% +$520K 1.63% 16
2022
Q1
$6M Buy
316,684
+102,970
+48% +$1.93M 1.13% 30
2021
Q4
$3.81M Buy
+213,714
New +$4.1M 0.68% 54
2018
Q1
Sell
-39,796
Closed -$921K 153
2017
Q4
$921K Buy
39,796
+30,000
+306% +$707K 0.12% 118
2017
Q3
$222K Buy
+9,796
New +$202K 0.03% 135
2017
Q2
Sell
-10,157
Closed -$345K 133
2017
Q1
$345K Sell
10,157
-179,318
-95% -$5.85M 0.07% 137
2016
Q4
$5.95M Buy
189,475
+158,175
+505% +$4.94M 1.38% 16
2016
Q3
$907K Hold
31,300
0.21% 128
2016
Q2
$923K Hold
31,300
0.22% 122
2016
Q1
$973K Hold
31,300
0.23% 118
2015
Q4
$1.11M Buy
+31,300
New +$1.17M 0.26% 115

Other funds holding IMAX

Formula Growth's IMAX Position: Q4 2023 in Review

Formula Growth sold out of IMAX (IMAX) in Q4 2023, closing a stake of 201,694 shares — an estimated $3.9M sold.

Formula Growth first reported a position in IMAX in Q4 2015 and held it in 16 quarters. The position peaked at $6M in Q1 2022. 172 funds tracked by Wall St. Rank hold IMAX as of Q4 2023.

  • Formula Growth reported no remaining IMAX position as of Q4 2023 after selling out during the quarter.
  • Formula Growth sold 201,694 IMAX shares in Q4 2023, an estimated $3.9M.
  • Formula Growth first reported a position in IMAX in Q4 2015 and held it in 16 quarters.
  • Formula Growth's IMAX position peaked at $6M in Q1 2022.
  • 172 funds tracked by Wall St. Rank held IMAX as of Q4 2023.

Based on Formula Growth's 13F filing for Q4 2023, filed 13 Feb 2024.